LNB
GSK icon

Ledyard National Bank’s GSK GSK Stock Holding History

Ledyard National Bank’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.53M Sell
48,213
-1,731
-3% -$91.5K 0.2% 84
2026
Q1 		$2.76M Buy
49,944
+640
+1% +$34.7K 0.24% 77
2025
Q4 		$2.42M Buy
49,304
+48
+0.1% +$2.24K 0.21% 81
2025
Q3 		$2.13M Sell
49,256
-493
-1% -$19.3K 0.19% 86
2025
Q2 		$1.91M Buy
49,749
+5,245
+12% +$200K 0.18% 88
2025
Q1 		$1.72M Buy
44,504
+5,960
+15% +$218K 0.17% 88
2024
Q4 		$1.3M Buy
38,544
+14,263
+59% +$513K 0.12% 97
2024
Q3 		$993K Buy
24,281
+4,712
+24% +$193K 0.09% 112
2024
Q2 		$753K Buy
19,569
+6,203
+46% +$261K 0.07% 121
2024
Q1 		$573K Buy
13,366
+6,597
+97% +$272K 0.06% 132
2023
Q4 		$251K Hold
6,769
– – 0.03% 190
2023
Q3 		$245K Hold
6,769
– – 0.03% 181
2023
Q2 		$241K Hold
6,769
– – 0.03% 194
2023
Q1 		$241K Sell
6,769
-290
-4% -$10.1K 0.03% 187
2022
Q4 		$248K Hold
7,059
– – 0.03% 183
2022
Q3 		$208K Sell
7,059
-3
-0% -$114 0.03% 197
2022
Q2 		$384K Sell
7,062
-299
-4% -$16.5K 0.05% 159
2022
Q1 		$401K Sell
7,361
-120
-2% -$6.52K 0.04% 168
2021
Q4 		$412K Sell
7,481
-240
-3% -$12.5K 0.04% 171
2021
Q3 		$369K Buy
7,721
+240
+3% +$12.1K 0.04% 180
2021
Q2 		$372K Hold
7,481
– – 0.04% 185
2021
Q1 		$334K Sell
7,481
-97
-1% -$4.4K 0.04% 190
2020
Q4 		$349K Sell
7,578
-80
-1% -$3.67K 0.04% 181
2020
Q3 		$360K Sell
7,658
-40
-0.5% -$2K 0.05% 173
2020
Q2 		$393K Hold
7,698
– – 0.05% 161
2020
Q1 		$365K Hold
7,698
– – 0.06% 172
2019
Q4 		$452K Buy
7,698
+240
+3% +$13.3K 0.05% 179
2019
Q3 		$398K Hold
7,458
– – 0.05% 192
2019
Q2 		$373K Sell
7,458
-116
-2% -$5.82K 0.05% 203
2019
Q1 		$396K Sell
7,574
-90
-1% -$4.5K 0.05% 205
2018
Q4 		$366K Hold
7,664
– – 0.05% 209
2018
Q3 		$385K Sell
7,664
-576
-7% -$29.3K 0.04% 218
2018
Q2 		$416K Sell
8,240
-2
-0% -$101 0.05% 213
2018
Q1 		$403K Hold
8,242
– – 0.05% 223
2017
Q4 		$365K Sell
8,242
-48
-0.6% -$2.22K 0.04% 237
2017
Q3 		$420K Hold
8,290
– – 0.06% 203
2017
Q2 		$447K Buy
8,290
+488
+6% +$26K 0.06% 178
2017
Q1 		$411K Buy
7,802
+6,904
+769% +$350K 0.06% 180
2016
Q4 		$44K Sell
898
-252
-22% -$12.4K 0.01% 325
2016
Q3 		$62K Buy
1,150
+320
+39% +$17.5K 0.01% 297
2016
Q2 		$45K Buy
830
+252
+44% +$13.3K 0.01% 310
2016
Q1 		$29K Sell
578
-353
-38% -$17.6K 0.01% 381
2015
Q4 		$47K Hold
931
– – 0.01% 318
2015
Q3 		$44K Sell
931
-133
-13% -$6.92K 0.01% 309
2015
Q2 		$55K Hold
1,064
– – 0.01% 291
2015
Q1 		$61K Buy
1,064
+133
+14% +$7.63K 0.01% 273
2014
Q4 		$49K Hold
931
– – 0.01% 302
2014
Q3 		$54K Hold
931
– – 0.01% 256
2014
Q2 		$62K Buy
931
+353
+61% +$23.9K 0.01% 251
2014
Q1 		$38K Hold
578
– – 0.01% 283
2013
Q4 		$38K Sell
578
-202
-26% -$13.1K 0.01% 284
2013
Q3 		$49K Hold
780
– – 0.01% 236
2013
Q2 		$49K Buy
+780
New +$49.5K 0.01% 226

Other funds holding GSK

JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return

Ledyard National Bank's GSK Position: Q2 2026 in Review

Ledyard National Bank reduced its GSK (GSK) stake by 3.5% in Q2 2026, selling an estimated $91.5K and leaving 48,213 shares worth $2.53M. The position accounts for 0.2% of the portfolio, ranked #84.

Ledyard National Bank first reported a position in GSK in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.76M in Q1 2026. 439 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Ledyard National Bank held 48,213 shares of GSK worth $2.53M as of Q2 2026.
  • Ledyard National Bank sold 1,731 GSK shares in Q2 2026, an estimated $91.5K.
  • GSK made up 0.2% of Ledyard National Bank's portfolio in Q2 2026, its #84 holding.
  • Ledyard National Bank first reported a position in GSK in Q2 2013 and has held it in 53 quarters since.
  • Ledyard National Bank's GSK position peaked at $2.76M in Q1 2026.
  • 439 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Ledyard National Bank's 13F filing for Q2 2026, filed 16 Jul 2026.